Literature DB >> 34061152

Concentration of Patient Care Among Buprenorphine-Prescribing Clinicians in the US.

Bradley D Stein1, Brendan Saloner2, Megan S Schuler3, Jill Gurvey3, Mark Sorbero1, Adam J Gordon4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34061152      PMCID： PMC8170540          DOI： 10.1001/jama.2021.4469

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  5 in total

1.  Overcoming Barriers to Treatment of Opioid Use Disorder.

Authors:  Yngvild Olsen; Ruchi M Fitzgerald; Sarah E Wakeman
Journal:  JAMA       Date:  2021-03-23       Impact factor: 56.272

2.  Prescribing patterns of buprenorphine waivered physicians.

Authors:  Cindy Parks Thomas; Erin Doyle; Peter W Kreiner; Christopher M Jones; Joel Dubenitz; Alexis Horan; Bradley D Stein
Journal:  Drug Alcohol Depend       Date:  2017-10-18       Impact factor: 4.492

3.  Physician Capacity to Treat Opioid Use Disorder With Buprenorphine-Assisted Treatment.

Authors:  Bradley D Stein; Mark Sorbero; Andrew W Dick; Rosalie Liccardo Pacula; Rachel M Burns; Adam J Gordon
Journal:  JAMA       Date:  2016-09-20       Impact factor: 56.272

4.  No end to the crisis without an end to the waiver.

Authors:  Joseph W Frank; Sarah E Wakeman; Adam J Gordon
Journal:  Subst Abus       Date:  2018       Impact factor: 3.716

5.  Monthly Patient Volumes of Buprenorphine-Waivered Clinicians in the US.

Authors:  Alexandra Duncan; Jared Anderman; Travis Deseran; Ian Reynolds; Bradley D Stein
Journal:  JAMA Netw Open       Date:  2020-08-03
  5 in total
  9 in total

1.  Opioid overdose survivors: Medications for opioid use disorder and risk of repeat overdose in Medicaid patients.

Authors:  Stephen Crystal; Molly Nowels; Hillary Samples; Mark Olfson; Arthur Robin Williams; Peter Treitler
Journal:  Drug Alcohol Depend       Date:  2022-01-10       Impact factor: 4.492

2.  Medicaid Managed Care: Access To Primary Care Providers Who Prescribe Buprenorphine.

Authors:  Mark Katz Meiselbach; Coleman Drake; Brendan Saloner; Jane M Zhu; Bradley D Stein; Daniel Polsky
Journal:  Health Aff (Millwood)       Date:  2022-06       Impact factor: 9.048

3.  Conceptualizing the Socio-Built Environment: An Expanded Theoretical Framework to Promote a Better Understanding of Risk for Nonmedical Opioid Overdose Outcomes in Urban and Non-Urban Settings.

Authors:  Barbara Tempalski; Leslie D Williams; Marynia Kolak; Danielle C Ompad; Julia Koschinsky; Sara L McLafferty
Journal:  J Urban Health       Date:  2022-06-07       Impact factor: 5.801

4.  Subsequent Buprenorphine Treatment Following Emergency Physician Buprenorphine Prescription Fills: A National Assessment 2019 to 2020.

Authors:  Bradley D Stein; Brendan Saloner; Rose Kerber; Mark Sorbero; Adam J Gordon
Journal:  Ann Emerg Med       Date:  2022-03-16       Impact factor: 6.762

5.  Buprenorphine prescriber monthly patient caseloads: An examination of 6-year trajectories.

Authors:  Irineo Cabreros; Beth Ann Griffin; Brendan Saloner; Adam J Gordon; Rose Kerber; Bradley D Stein
Journal:  Drug Alcohol Depend       Date:  2021-09-22       Impact factor: 4.492

6.  Champions Among Us: Leading Primary Care to the Forefront of Opioid Use Disorder Treatment.

Authors:  Michael A Incze; A Taylor Kelley; Adam J Gordon
Journal:  J Gen Intern Med       Date:  2022-01-11       Impact factor: 6.473

7.  Prescribers' satisfaction with delivering medications for opioid use disorder.

Authors:  Hannah K Knudsen; Randy Brown; Nora Jacobson; Julie Horst; Jee-Seon Kim; Hanna Kim; Lynn M Madden; Eric Haram; Todd Molfenter
Journal:  Subst Abuse Treat Prev Policy       Date:  2021-10-18

8.  Use of Medication for Opioid Use Disorder Among US Adolescents and Adults With Need for Opioid Treatment, 2019.

Authors:  Pia M Mauro; Sarah Gutkind; Erin M Annunziato; Hillary Samples
Journal:  JAMA Netw Open       Date:  2022-03-01

9.  Reducing opioid use disorder and overdose deaths in the United States: A dynamic modeling analysis.

Authors:  Erin J Stringfellow; Tse Yang Lim; Keith Humphreys; Catherine DiGennaro; Celia Stafford; Elizabeth Beaulieu; Jack Homer; Wayne Wakeland; Benjamin Bearnot; R Kathryn McHugh; John Kelly; Lukas Glos; Sara L Eggers; Reza Kazemi; Mohammad S Jalali
Journal:  Sci Adv       Date:  2022-06-24       Impact factor: 14.957
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.